Skip to main content
. 2022 Jan 19;322(3):C354–C369. doi: 10.1152/ajpcell.00411.2021

Table 1.

Chemokine quantification in MRcko mdx and WT skeletal muscle

CCL2 CCL3 CCL4 CCL5 CCL12 CXCL1 CXCL2 CXCL9 CXCL10 CXCL13
Coordinate C5 C8 C9 C11 C6 C3 C10 C14 C1 A1
MRcko
mdx 4WK QUAD ↓29% ↓80% ↑4.9× ↓5% ↓47% ↑1.9× N.D. ↑2.0× ↑3.6× ↓9%
mdx 4WK DIA ↓11% ↓65% ↓52% ↓72% ↓20% ↓15% ↓66% ↓53% ↓30% ↓18%
 WT AID4 TA === ↓54% N.D. ↓18% ↓9% ↓87% N.D. ↓14% N.D. ↓14%

Quantification of relative chemokine levels detected in myeloid mineralocorticoid receptor knockout (MRcko) mdx and injured MRcko wild-type (WT) skeletal muscle by pixel densitometry. Results are displayed as fold increases and % decreases in MRcko skeletal muscle relative to the appropriate Cre controls. Coordinates listed in the table correspond to the individual chemokine’s location (in duplicate) on the immunoblot. Some quantified chemokines were equivalent (===) or not detected (N.D.) compared with Cre controls. AID4, 4 days after acute injury; DIA, diaphragm; QUAD, quadriceps; TA, tibialis anterior; 4WK, 4 wk of age.